Analyst Reco. Bio-Techne Corporation

Equities

TECH

US09073M1045

Real-time Estimate Cboe BZX Other stock markets 11:38:15 2024-04-25 am EDT			5-day change	1st Jan Change
62.02 ^USD	-2.35%		-0.12%	-19.47%

Apr. 23	Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe	MT
Apr. 18	Deutsche Bank Adjusts Bio-Techne Price Target to $82 From $85	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Deutsche Bank Adjusts Bio-Techne Price Target to $82 From $85	Apr. 18	MT
RBC Raises Price Target on Bio-Techne to $79 From $75, Keeps Sector Perform Rating	Apr. 08	MT
Stephens Adjusts Bio-Techne's Price Target to $87 From $70, Keeps Overweight Rating	Feb. 02	MT
Deutsche Bank Cuts Bio-Techne Price Target to $85 From $88, Maintains Buy Rating	Feb. 02	MT
RBC Cuts Price Target on Bio-Techne to $75 From $85, Notes Revenue Growth Turned Negative, Keeps Sector Perform Rating	Feb. 02	MT
Stifel Nicolaus Downgrades Bio-Techne to Hold from Buy, $65 Price Target	Feb. 02	MT
UBS Initiates Coverage on Bio-Techne With Buy Rating, $80 Price Target	Dec. 07	MT
Deutsche Bank Cuts Bio-Techne Price Target to $70 From $100, Maintains Buy Rating	Nov. 01	MT
KeyBanc Cuts Price Target on Bio-Techne to $80 From $115, Maintains Overweight Rating	Nov. 01	MT
RBC Trims Price Target on Bio-Techne to $83 From $85, Keeps Sector Perform Rating	Nov. 01	MT
William Blair Initiates Coverage on Bio-Techne with Outperform Rating	23-08-28	MT
RBC Trims Bio-Techne's Price Target to $87 From $88, Keeps Sector Perform Rating	23-07-17	MT
RBC Trims Price Target on Bio-Techne to $88 From $90, Maintains Sector Perform Rating	23-05-15	MT
Baird Adjusts Price Target on Bio-Techne to $100 From $99, Maintains Outperform Rating	23-05-04	MT
RBC Lifts Price Target on Bio-Techne to $90 From $89 on View for Better 2024 EBITDA Margins, Keeps Sector Perform Rating	23-05-04	MT
RBC Lifts Price Target on Bio-Techne to $89 From $88, Maintains Sector Perform Rating	23-04-14	MT
RBC Lifts Price Target on Bio-Techne to $89 From $88, Maintains Sector Perform Rating	23-04-13	MT
RBC Trims Price Target on Bio-Techne to $88 From $89 After Fiscal Q2 Miss, Maintains Sector Perform Rating	23-02-06	MT
SVB Securities Lowers Price Target on Bio-Techne to $110 From $125, Maintains Outperform Rating	23-02-03	MT
Wells Fargo Upgrades Bio-Techne to Equalweight From Underweight, Price Target is $90	23-01-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Bio-Techne Corporation

Equities

TECH

US09073M1045

Analyst Reco.

Filters